Vice President, Investor Relations & Corporate Communications

About the role

Location: Cambridge, MA, USA – on‑site (with flexible/hybrid working). Reporting to the Chief Financial Officer. Hemab is building preventative treatments for serious, underserved bleeding disorders. The role is Vice President, Investor Relations & Corporate Communications, responsible for day‑to‑day investor relations and building external and internal communications functions, partnering with the CFO, CEO, and executive team.

Responsibilities

• Build and lead Hemab's communications function, consolidating work across teams into a clear, effective model.
• Translate complex science, clinical data, and company milestones into accurate, compelling communications for patients, physicians, employees, media, and investors, working closely with Medical Affairs.
• Set Hemab's corporate narrative and communications agenda, creating messaging, content, and a forward calendar for proactive communication.
• Run day‑to‑day investor relations alongside the CEO and CFO, strengthening the IR calendar, materials, investor preparation, and ways of working while they lead principal investor and analyst relationships.
• Build public‑company communications capabilities, including earnings communications, corporate presentations, SEC‑related communications, disclosure controls, and preparation for events such as R&D days.
• Lead external communications across media, corporate channels, and executive communications, using evidence and audience response to guide investment of time.
• Lead internal communications to keep colleagues in Cambridge and Copenhagen aligned and connected as the company grows, partnering with People and Culture on employer brand.
• Manage external IR and communications partners and collaborate with Finance, Legal, Medical Affairs, Patient Advocacy, Clinical, and People and Culture to ensure accuracy, coordination, and usefulness.

Requirements / Qualifications

• Senior communications leadership experience in biotech, with evidence of building or significantly developing a communications capability rather than merely inheriting one.
• Ability to understand complex scientific and clinical information and turn it into clear communications without losing accuracy or nuance.
• Experience working closely with Medical Affairs, clinical or scientific colleagues on data‑driven communications.
• Meaningful public‑company investor relations experience, including familiarity with SEC disclosure requirements, Reg FD, and investor‑facing communications.
• Experience advising CEOs, CFOs, or other senior leaders on communications, investor messaging, and sensitive public‑facing decisions.
• Strong writing and editorial judgement across scientific, corporate, investor, and employee audiences.

Key Skills

• Strategic, critical thinker with strong executive presence and ability to counsel senior leaders.
• Data‑driven approach to content, campaign, and channel strategy.
• Excellent judgment on messaging consistency, tone, and reputational risk.
• Strong project management skills with ability to manage multiple priorities and stakeholders.
• Collaborative, hands‑on style suited to a fast‑paced, growing organization.
• Proficiency in using AI tools to enhance productivity and content quality.
• Ability to work effectively across a global organization spanning U.S. and European offices.

What to Expect

Hemab is still building much of its own structure; systems are created as needed, so the role will involve building processes rather than inheriting a finished one. The company works across two hubs (Cambridge, MA and Copenhagen, Denmark) and multiple time zones, requiring deliberate effort to bridge them. Priorities can shift quickly as the company grows. This environment is energizing for those who want to help shape the operating manual, but may be frustrating for those seeking a fully established playbook.

Why Hemab

At Hemab, your work connects directly to preventing bleeds for patients with serious bleeding disorders, offering a chance to stop a bleed before it happens rather than reacting after. You will join at a stage where individual decisions carry real weight and your work can help turn promising science into a preventative treatment that reaches patients. Hemab aims to treat people with care, honesty, and respect, extending that mindset to employees, and is building consistency across hiring processes. The company builds balanced candidate slates and assesses everyone against a single standard, and will provide reasonable adjustments upon request.